Compare FANG & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FANG | VTR |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Real Estate Investment Trusts |
| Sector | Energy | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.3B | 45.0B |
| IPO Year | 2012 | 2005 |
| Metric | FANG | VTR |
|---|---|---|
| Price | $189.86 | $92.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 13 |
| Target Price | ★ $213.82 | $87.62 |
| AVG Volume (30 Days) | 2.2M | ★ 2.7M |
| Earning Date | 05-04-2026 | 04-27-2026 |
| Dividend Yield | 2.05% | ★ 2.38% |
| EPS Growth | N/A | ★ 184.21 |
| EPS | 0.08 | ★ 0.11 |
| Revenue | ★ $15,026,000,000.00 | $5,833,980,000.00 |
| Revenue This Year | $12.05 | $14.00 |
| Revenue Next Year | N/A | $8.35 |
| P/E Ratio | $2,380.25 | ★ $840.95 |
| Revenue Growth | ★ 35.79 | 18.47 |
| 52 Week Low | $134.30 | $65.12 |
| 52 Week High | $214.51 | $94.60 |
| Indicator | FANG | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 54.05 | 61.91 |
| Support Level | $188.02 | $84.56 |
| Resistance Level | $212.33 | $94.60 |
| Average True Range (ATR) | 4.83 | 1.92 |
| MACD | 1.93 | 0.24 |
| Stochastic Oscillator | 83.10 | 69.89 |
Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.